Answers are grounded in this paper and cite their sources.
Achillea santolina is traditionally used for its anti-inflammatory properties. This study analysed the chemical composition of A. santolina essential oil (AS-EO) and evaluated its effects on LPS-induced pro-inflammatory gene expression in RAW264.7 macrophages. GC-MS analysis identified 13 compounds (93.2% of the oil), while 3 peaks (6.8%) remained unidentified. The oil was predominantly composed of monoterpenes (86.2%), with oxygenated monoterpenes representing 76.7%, featuring 1,8-cineole (20.2%), camphor (18.1%), and 4-terpineol (18.0%) as major components. AS-EO showed low cytotoxicity at concentrations up to 50 μg/mL. Pre-treatment with AS-EO (5–50 μg/mL) dose-dependently suppressed LPS-induced mRNA expression of TNF-α, IL-6, IL-1β, and COX-2, achieving maximum inhibition of 60.3%, 65.1%, 59.8%, and 54.7%, respectively, at 50 μg/mL (p < 0.0001). Assay validity was confirmed using dexamethasone (10 μM), which strongly inhibited gene expression (up to 95.2%, p < 0.0001). These findings indicate that AS-EO attenuates LPS-induced inflammatory gene expression in vitro, although the effects should be interpreted cautiously given the reduced viability at the highest concentration tested.
No takes yet. Share an insight, caveat, or question.
Althaher et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: